Connor, Clark & Lunn Investment Management Ltd.

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in LRMR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$182,353

-$128,538 QoQ

Shares Held

59,788

-13.5% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#68

of 163 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. LRMR ranks #94 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$182,353	59,788	-13.5%	Shares	Sole	2026-08-13
2026-03-31	$310,891	69,087	+227.9%	Shares	Sole	2026-05-11
2025-12-31	$80,276	21,070	-10.4%	Shares	Sole	2026-02-10
2024-09-30	$154,062	23,521	-1.3%	Shares	Sole	2024-11-08
2024-06-30	$172,782	23,832	-59.0%	Shares	Sole	2024-08-09
2024-03-31	$441,100	58,116	+166.2%	Shares	Sole	2024-05-09
2023-09-30	$86,248	21,835	-54.6%	Shares	Sole	2023-11-13
2023-06-30	$150,471	48,074	+14.9%	Shares	Sole	2023-08-10
2023-03-31	$189,566	41,847	+11.6%	Shares	Sole	2023-05-10
2022-12-31	$154,813	37,485	+186.9%	Shares	Sole	2023-02-10
2022-09-30	$41,808	13,065	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.